{"entity":{"type":"insider","cik":"0001450324","url":"/insider/0001450324","json_url":"/insider/0001450324.json","name":"Equels Thomas K","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":67,"n_filings":51,"first":"2015-04-15","last":"2025-06-16","span_basis":"filed_date"},"name_variants":[{"name":"Equels Thomas K","source":"filing","n_filings":21,"first_seen":"2023-01-04","last_seen":"2025-06-16"},{"name":"EQUELS THOMAS K.","source":"filing","n_filings":15,"first_seen":"2018-04-30","last_seen":"2021-07-16"},{"name":"Equels Thomas K.","source":"filing","n_filings":15,"first_seen":"2015-04-15","last_seen":"2017-04-27"}],"transactions":[{"id":4149330,"accession":"0001641172-25-015207","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001641172-25-015207","line_url":"/filing/0001641172-25-015207#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":107.0,"shares_display":"107","price_per_share":7.697,"price_display":"7.70","price_state":"stated","total_value":823.579,"total_display":"823.58","shares_owned_after":38885.0,"shares_owned_after_display":"38,885","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-13","filed_date":"2025-06-16","scope":"insider"},{"id":5202871,"accession":"0001641172-25-015005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001641172-25-015005","line_url":"/filing/0001641172-25-015005#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":103.0,"shares_display":"103","price_per_share":8.7,"price_display":"8.70","price_state":"stated","total_value":896.1,"total_display":"896.10","shares_owned_after":38675.0,"shares_owned_after_display":"38,675","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-12","filed_date":"2025-06-13","scope":"insider"},{"id":4240456,"accession":"0001641172-25-005861","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001641172-25-005861","line_url":"/filing/0001641172-25-005861#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1968504.0,"shares_display":"1,968,504","price_per_share":0.0254,"price_display":"0.03","price_state":"stated","total_value":50000.0016,"total_display":"50,000.00","shares_owned_after":3867533.0,"shares_owned_after_display":"3,867,533","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-11","filed_date":"2025-04-23","scope":"insider"},{"id":4183743,"accession":"0001641172-25-002977","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001641172-25-002977","line_url":"/filing/0001641172-25-002977#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":41000.0,"shares_display":"41,000","price_per_share":0.063,"price_display":"0.06","price_state":"stated","total_value":2583.0,"total_display":"2,583.00","shares_owned_after":1899029.0,"shares_owned_after_display":"1,899,029","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-04","filed_date":"2025-04-07","scope":"insider"},{"id":4893159,"accession":"0001493152-25-009338","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-009338","line_url":"/filing/0001493152-25-009338#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.1346,"price_display":"0.13","price_state":"stated","total_value":6730.0,"total_display":"6,730.00","shares_owned_after":1858029.0,"shares_owned_after_display":"1,858,029","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-06","scope":"insider"},{"id":4925845,"accession":"0001493152-25-009003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-009003","line_url":"/filing/0001493152-25-009003#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":83334.0,"shares_display":"83,334","price_per_share":0.12,"price_display":"0.12","price_state":"stated","total_value":10000.08,"total_display":"10,000.08","shares_owned_after":1764029.0,"shares_owned_after_display":"1,764,029","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-04","scope":"insider"},{"id":4178599,"accession":"0001493152-25-009164","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-009164","line_url":"/filing/0001493152-25-009164#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":44000.0,"shares_display":"44,000","price_per_share":0.115,"price_display":"0.12","price_state":"stated","total_value":5060.0,"total_display":"5,060.00","shares_owned_after":1808029.0,"shares_owned_after_display":"1,808,029","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-05","scope":"insider"},{"id":3081733,"accession":"0001493152-24-050757","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-050757","line_url":"/filing/0001493152-24-050757#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22727.0,"shares_display":"22,727","price_per_share":0.206,"price_display":"0.21","price_state":"stated","total_value":4681.762,"total_display":"4,681.76","shares_owned_after":1680695.0,"shares_owned_after_display":"1,680,695","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-18","filed_date":"2024-12-19","scope":"insider"},{"id":4648704,"accession":"0001493152-25-003058","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-25-003058","line_url":"/filing/0001493152-25-003058#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.212,"price_display":"0.21","price_state":"stated","total_value":4240.0,"total_display":"4,240.00","shares_owned_after":1657968.0,"shares_owned_after_display":"1,657,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-21","filed_date":"2025-01-21","scope":"insider"},{"id":3205946,"accession":"0001493152-24-046952","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-046952","line_url":"/filing/0001493152-24-046952#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60110.0,"shares_display":"60,110","price_per_share":0.183,"price_display":"0.18","price_state":"stated","total_value":11000.13,"total_display":"11,000.13","shares_owned_after":1552968.0,"shares_owned_after_display":"1,552,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-20","filed_date":"2024-11-20","scope":"insider"},{"id":2186148,"accession":"0001493152-24-047094","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-047094","line_url":"/filing/0001493152-24-047094#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":85000.0,"shares_display":"85,000","price_per_share":0.199,"price_display":"0.20","price_state":"stated","total_value":16915.0,"total_display":"16,915.00","shares_owned_after":1637968.0,"shares_owned_after_display":"1,637,968","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-20","filed_date":"2024-11-21","scope":"insider"},{"id":2506645,"accession":"0001493152-24-036837","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-036837","line_url":"/filing/0001493152-24-036837#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":0.303,"price_display":"0.30","price_state":"stated","total_value":1515.0,"total_display":"1,515.00","shares_owned_after":1493042.0,"shares_owned_after_display":"1,493,042","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-16","filed_date":"2024-09-17","scope":"insider"},{"id":2356131,"accession":"0001493152-24-036364","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-036364","line_url":"/filing/0001493152-24-036364#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.308,"price_display":"0.31","price_state":"stated","total_value":6160.0,"total_display":"6,160.00","shares_owned_after":1488042.0,"shares_owned_after_display":"1,488,042","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-13","filed_date":"2024-09-16","scope":"insider"},{"id":2400317,"accession":"0001493152-24-018030","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-018030","line_url":"/filing/0001493152-24-018030#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":61729.0,"shares_display":"61,729","price_per_share":0.405,"price_display":"0.40","price_state":"stated","total_value":25000.245,"total_display":"25,000.24","shares_owned_after":778184.0,"shares_owned_after_display":"778,184","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-06","filed_date":"2024-05-07","scope":"insider"},{"id":2819653,"accession":"0001493152-24-010267","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-24-010267","line_url":"/filing/0001493152-24-010267#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":75758.0,"shares_display":"75,758","price_per_share":0.33,"price_display":"0.33","price_state":"stated","total_value":25000.14,"total_display":"25,000.14","shares_owned_after":716455.0,"shares_owned_after_display":"716,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-15","filed_date":"2024-03-18","scope":"insider"},{"id":7847842,"accession":"0001493152-23-042743","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-042743","line_url":"/filing/0001493152-23-042743#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33861.0,"shares_display":"33,861","price_per_share":0.443,"price_display":"0.44","price_state":"stated","total_value":15000.423,"total_display":"15,000.42","shares_owned_after":640697.0,"shares_owned_after_display":"640,697","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-27","filed_date":"2023-11-27","scope":"insider"},{"id":7976622,"accession":"0001493152-23-034802","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-034802","line_url":"/filing/0001493152-23-034802#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22676.0,"shares_display":"22,676","price_per_share":0.441,"price_display":"0.44","price_state":"stated","total_value":10000.116,"total_display":"10,000.12","shares_owned_after":606836.0,"shares_owned_after_display":"606,836","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-29","filed_date":"2023-09-29","scope":"insider"},{"id":8037426,"accession":"0001493152-23-030180","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-030180","line_url":"/filing/0001493152-23-030180#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8222.0,"shares_display":"8,222","price_per_share":0.669,"price_display":"0.67","price_state":"stated","total_value":5500.518,"total_display":"5,500.52","shares_owned_after":584160.0,"shares_owned_after_display":"584,160","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-25","filed_date":"2023-08-25","scope":"insider"},{"id":8300469,"accession":"0001493152-23-030077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-030077","line_url":"/filing/0001493152-23-030077#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14993.0,"shares_display":"14,993","price_per_share":0.667,"price_display":"0.67","price_state":"stated","total_value":10000.331,"total_display":"10,000.33","shares_owned_after":575938.0,"shares_owned_after_display":"575,938","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-24","filed_date":"2023-08-24","scope":"insider"},{"id":8746700,"accession":"0001493152-23-024767","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-024767","line_url":"/filing/0001493152-23-024767#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16950.0,"shares_display":"16,950","price_per_share":0.59,"price_display":"0.59","price_state":"stated","total_value":10000.5,"total_display":"10,000.50","shares_owned_after":560945.0,"shares_owned_after_display":"560,945","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-17","filed_date":"2023-07-17","scope":"insider"},{"id":7942596,"accession":"0001493152-23-000211","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-000211","line_url":"/filing/0001493152-23-000211#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":161291.0,"shares_display":"161,291","price_per_share":0.31,"price_display":"0.31","price_state":"stated","total_value":50000.21,"total_display":"50,000.21","shares_owned_after":543995.0,"shares_owned_after_display":"543,995","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-04","scope":"insider"},{"id":4231633,"accession":"0001450324-21-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001450324-21-000002","line_url":"/filing/0001450324-21-000002#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"EQUELS THOMAS K.","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15625.0,"shares_display":"15,625","price_per_share":1.92,"price_display":"1.92","price_state":"stated","total_value":30000.0,"total_display":"30,000.00","shares_owned_after":225255.0,"shares_owned_after_display":"225,255","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-16","filed_date":"2021-07-16","scope":"insider"},{"id":5484565,"accession":"0001450324-21-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001450324-21-000001","line_url":"/filing/0001450324-21-000001#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"EQUELS THOMAS K.","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":11062.0,"shares_display":"11,062","price_per_share":2.26,"price_display":"2.26","price_state":"stated","total_value":25000.12,"total_display":"25,000.12","shares_owned_after":209630.0,"shares_owned_after_display":"209,630","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-24","filed_date":"2021-02-24","scope":"insider"},{"id":2813142,"accession":"0001450324-20-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001450324-20-000008","line_url":"/filing/0001450324-20-000008#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"EQUELS THOMAS K.","owner_url":"/insider/0001450324","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14535.0,"shares_display":"14,535","price_per_share":1.72,"price_display":"1.72","price_state":"stated","total_value":25000.2,"total_display":"25,000.20","shares_owned_after":198568.0,"shares_owned_after_display":"198,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-17","filed_date":"2020-12-17","scope":"insider"},{"id":2846748,"accession":"0001450324-20-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001450324-20-000006","line_url":"/filing/0001450324-20-000006#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"EQUELS THOMAS K.","owner_url":"/insider/0001450324","role":"Director, Officer (CEO & President)","officer_title":"CEO & President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12316.0,"shares_display":"12,316","price_per_share":2.03,"price_display":"2.03","price_state":"stated","total_value":25001.48,"total_display":"25,001.48","shares_owned_after":184033.0,"shares_owned_after_display":"184,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-03","filed_date":"2020-09-03","scope":"insider"},{"id":3298877,"accession":"0001450324-20-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001450324-20-000005","line_url":"/filing/0001450324-20-000005#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"AIM ImmunoTech Inc.","issuer_ticker":"AIM","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"EQUELS THOMAS K.","owner_url":"/insider/0001450324","role":"Director, Officer (CEO)","officer_title":"CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10730.0,"shares_display":"10,730","price_per_share":2.33,"price_display":"2.33","price_state":"stated","total_value":25000.9,"total_display":"25,000.90","shares_owned_after":171717.0,"shares_owned_after_display":"171,717","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-21","filed_date":"2020-08-21","scope":"insider"},{"id":7901516,"accession":"0001450324-19-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001450324-19-000012","line_url":"/filing/0001450324-19-000012#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"EQUELS THOMAS K.","owner_url":"/insider/0001450324","role":"Director, Officer (Exec. Vice Chairman/CEO/Pres)","officer_title":"Exec. Vice Chairman/CEO/Pres.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2632.0,"shares_display":"2,632","price_per_share":4.37,"price_display":"4.37","price_state":"stated","total_value":11501.84,"total_display":"11,501.84","shares_owned_after":63041.0,"shares_owned_after_display":"63,041","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-27","filed_date":"2019-06-27","scope":"insider"},{"id":9295132,"accession":"0001702626-19-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001702626-19-000006","line_url":"/filing/0001702626-19-000006#line-1","is_derivative":false,"issuer_cik":"0001450324","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0001450324","owner_cik":"0001450324","owner_name":"EQUELS THOMAS K.","owner_url":"/insider/0001450324","role":"Director, Officer (Exec. Vice Chairman/CEO/Pres)","officer_title":"Exec. Vice Chairman/CEO/Pres.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":29404.0,"shares_display":"29,404","price_per_share":4.03,"price_display":"4.03","price_state":"stated","total_value":118498.12,"total_display":"118,498.12","shares_owned_after":60409.0,"shares_owned_after_display":"60,409","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-21","filed_date":"2019-06-25","scope":"insider"},{"id":8135519,"accession":"0001450324-19-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001450324-19-000011","line_url":"/filing/0001450324-19-000011#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"EQUELS THOMAS K.","owner_url":"/insider/0001450324","role":"Director, Officer (Exec. Vice Chairman/CEO/Pres)","officer_title":"Exec. Vice Chairman/CEO/Pres.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":29404.0,"shares_display":"29,404","price_per_share":4.03,"price_display":"4.03","price_state":"stated","total_value":118498.12,"total_display":"118,498.12","shares_owned_after":1393611.0,"shares_owned_after_display":"1,393,611","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-21","filed_date":"2019-06-21","scope":"insider"},{"id":8684261,"accession":"0001450324-19-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001450324-19-000009","line_url":"/filing/0001450324-19-000009#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"EQUELS THOMAS K.","owner_url":"/insider/0001450324","role":"Director, Officer (Exec. Vice Chairman/CEO/Pres)","officer_title":"Exec. Vice Chairman/CEO/Pres.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13400.0,"shares_display":"13,400","price_per_share":0.1755,"price_display":"0.18","price_state":"stated","total_value":2351.7,"total_display":"2,351.70","shares_owned_after":811707.0,"shares_owned_after_display":"811,707","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-19","filed_date":"2019-03-19","scope":"insider"},{"id":6422938,"accession":"0001450324-18-000008","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001450324-18-000008","line_url":"/filing/0001450324-18-000008#line-8","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"EQUELS THOMAS K.","owner_url":"/insider/0001450324","role":"Director, Officer (Exec. Vice Chairman/CEO/Pres)","officer_title":"Exec. Vice Chairman/CEO/Pres.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9557.0,"shares_display":"9,557","price_per_share":0.19,"price_display":"0.19","price_state":"stated","total_value":1815.83,"total_display":"1,815.83","shares_owned_after":789223.0,"shares_owned_after_display":"789,223","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-30","filed_date":"2018-12-03","scope":"insider"},{"id":6422936,"accession":"0001450324-18-000008","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001450324-18-000008","line_url":"/filing/0001450324-18-000008#line-7","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"EQUELS THOMAS K.","owner_url":"/insider/0001450324","role":"Director, Officer (Exec. Vice Chairman/CEO/Pres)","officer_title":"Exec. Vice Chairman/CEO/Pres.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000.0,"shares_display":"6,000","price_per_share":0.196,"price_display":"0.20","price_state":"stated","total_value":1176.0,"total_display":"1,176.00","shares_owned_after":798307.0,"shares_owned_after_display":"798,307","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-30","filed_date":"2018-12-03","scope":"insider"},{"id":6422934,"accession":"0001450324-18-000008","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001450324-18-000008","line_url":"/filing/0001450324-18-000008#line-6","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"EQUELS THOMAS K.","owner_url":"/insider/0001450324","role":"Director, Officer (Exec. Vice Chairman/CEO/Pres)","officer_title":"Exec. Vice Chairman/CEO/Pres.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2400.0,"shares_display":"2,400","price_per_share":0.193,"price_display":"0.19","price_state":"stated","total_value":463.2,"total_display":"463.20","shares_owned_after":791623.0,"shares_owned_after_display":"791,623","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-30","filed_date":"2018-12-03","scope":"insider"},{"id":6422931,"accession":"0001450324-18-000008","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001450324-18-000008","line_url":"/filing/0001450324-18-000008#line-5","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"EQUELS THOMAS K.","owner_url":"/insider/0001450324","role":"Director, Officer (Exec. Vice Chairman/CEO/Pres)","officer_title":"Exec. Vice Chairman/CEO/Pres.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1354.0,"shares_display":"1,354","price_per_share":0.1891,"price_display":"0.19","price_state":"stated","total_value":256.0414,"total_display":"256.04","shares_owned_after":779661.0,"shares_owned_after_display":"779,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-30","filed_date":"2018-12-03","scope":"insider"},{"id":6422928,"accession":"0001450324-18-000008","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001450324-18-000008","line_url":"/filing/0001450324-18-000008#line-4","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"EQUELS THOMAS K.","owner_url":"/insider/0001450324","role":"Director, Officer (Exec. Vice Chairman/CEO/Pres)","officer_title":"Exec. Vice Chairman/CEO/Pres.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":334.0,"shares_display":"334","price_per_share":0.1945,"price_display":"0.19","price_state":"stated","total_value":64.963,"total_display":"64.96","shares_owned_after":792307.0,"shares_owned_after_display":"792,307","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-30","filed_date":"2018-12-03","scope":"insider"},{"id":6422925,"accession":"0001450324-18-000008","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001450324-18-000008","line_url":"/filing/0001450324-18-000008#line-3","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"EQUELS THOMAS K.","owner_url":"/insider/0001450324","role":"Director, Officer (Exec. Vice Chairman/CEO/Pres)","officer_title":"Exec. Vice Chairman/CEO/Pres.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":0.1944,"price_display":"0.19","price_state":"stated","total_value":58.32,"total_display":"58.32","shares_owned_after":791973.0,"shares_owned_after_display":"791,973","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-30","filed_date":"2018-12-03","scope":"insider"},{"id":6422922,"accession":"0001450324-18-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001450324-18-000008","line_url":"/filing/0001450324-18-000008#line-2","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"EQUELS THOMAS K.","owner_url":"/insider/0001450324","role":"Director, Officer (Exec. Vice Chairman/CEO/Pres)","officer_title":"Exec. Vice Chairman/CEO/Pres.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50.0,"shares_display":"50","price_per_share":0.1938,"price_display":"0.19","price_state":"stated","total_value":9.69,"total_display":"9.69","shares_owned_after":791673.0,"shares_owned_after_display":"791,673","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-30","filed_date":"2018-12-03","scope":"insider"},{"id":6422919,"accession":"0001450324-18-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001450324-18-000008","line_url":"/filing/0001450324-18-000008#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"EQUELS THOMAS K.","owner_url":"/insider/0001450324","role":"Director, Officer (Exec. Vice Chairman/CEO/Pres)","officer_title":"Exec. Vice Chairman/CEO/Pres.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5.0,"shares_display":"5","price_per_share":0.1892,"price_display":"0.19","price_state":"stated","total_value":0.946,"total_display":"0.95","shares_owned_after":779666.0,"shares_owned_after_display":"779,666","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-30","filed_date":"2018-12-03","scope":"insider"},{"id":6919386,"accession":"0001450324-18-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001450324-18-000007","line_url":"/filing/0001450324-18-000007#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"EQUELS THOMAS K.","owner_url":"/insider/0001450324","role":"Director, Officer (Exec. Vice Chairman/CEO/Pres)","officer_title":"Exec. Vice Chairman/CEO/Pres.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":0.203,"price_display":"0.20","price_state":"stated","total_value":710.5,"total_display":"710.50","shares_owned_after":775807.0,"shares_owned_after_display":"775,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-26","filed_date":"2018-10-29","scope":"insider"},{"id":6565196,"accession":"0001450324-18-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001450324-18-000006","line_url":"/filing/0001450324-18-000006#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"EQUELS THOMAS K.","owner_url":"/insider/0001450324","role":"Director, Officer (Exec. Vice Chairman/CEO/Pres)","officer_title":"Exec. Vice Chairman/CEO/Pres.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":0.2,"price_display":"0.20","price_state":"stated","total_value":20000.0,"total_display":"20,000.00","shares_owned_after":772307.0,"shares_owned_after_display":"772,307","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-25","filed_date":"2018-10-25","scope":"insider"},{"id":5973369,"accession":"0001450324-18-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001450324-18-000005","line_url":"/filing/0001450324-18-000005#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"EQUELS THOMAS K.","owner_url":"/insider/0001450324","role":"Director, Officer (Exec. Vice Chairman/CEO/Pres)","officer_title":"Exec. Vice Chairman/CEO/Pres.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34483.0,"shares_display":"34,483","price_per_share":0.29,"price_display":"0.29","price_state":"stated","total_value":10000.07,"total_display":"10,000.07","shares_owned_after":672306.0,"shares_owned_after_display":"672,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-27","filed_date":"2018-07-27","scope":"insider"},{"id":6355978,"accession":"0001613377-18-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001613377-18-000020","line_url":"/filing/0001613377-18-000020#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"EQUELS THOMAS K.","owner_url":"/insider/0001450324","role":"Director, Officer (Exec. Vice Chairman/CEO/Pres)","officer_title":"Exec. Vice Chairman/CEO/Pres.","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":112904.0,"shares_display":"112,904","price_per_share":0.31,"price_display":"0.31","price_state":"stated","total_value":35000.24,"total_display":"35,000.24","shares_owned_after":637823.0,"shares_owned_after_display":"637,823","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-07-23","filed_date":"2018-07-23","scope":"insider"},{"id":6565193,"accession":"0001450324-18-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001450324-18-000002","line_url":"/filing/0001450324-18-000002#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"EQUELS THOMAS K.","owner_url":"/insider/0001450324","role":"Director, Officer (CEO, President)","officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":32000.0,"shares_display":"32,000","price_per_share":0.32,"price_display":"0.32","price_state":"stated","total_value":10240.0,"total_display":"10,240.00","shares_owned_after":524919.0,"shares_owned_after_display":"524,919","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-04-27","filed_date":"2018-04-30","scope":"insider"},{"id":4678131,"accession":"0001450324-17-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001450324-17-000002","line_url":"/filing/0001450324-17-000002#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K.","owner_url":"/insider/0001450324","role":"Director, Officer (CEO, President)","officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":72464.0,"shares_display":"72,464","price_per_share":0.69,"price_display":"0.69","price_state":"stated","total_value":50000.16,"total_display":"50,000.16","shares_owned_after":492919.0,"shares_owned_after_display":"492,919","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-27","filed_date":"2017-04-27","scope":"insider"},{"id":4241890,"accession":"0001450324-17-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001450324-17-000001","line_url":"/filing/0001450324-17-000001#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K.","owner_url":"/insider/0001450324","role":"Director, Officer (CEO, President)","officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":100000.0,"total_display":"100,000.00","shares_owned_after":420455.0,"shares_owned_after_display":"420,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-11","filed_date":"2017-04-11","scope":"insider"},{"id":2760805,"accession":"0001450324-16-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001450324-16-000016","line_url":"/filing/0001450324-16-000016#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K.","owner_url":"/insider/0001450324","role":"Director, Officer (CEO, President)","officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68493.0,"shares_display":"68,493","price_per_share":0.73,"price_display":"0.73","price_state":"stated","total_value":49999.89,"total_display":"49,999.89","shares_owned_after":220455.0,"shares_owned_after_display":"220,455","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-22","filed_date":"2016-12-23","scope":"insider"},{"id":3025004,"accession":"0001450324-16-000015","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001450324-16-000015","line_url":"/filing/0001450324-16-000015#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K.","owner_url":"/insider/0001450324","role":"Director, Officer (CEO,President)","officer_title":"CEO,President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":10000.0,"total_display":"10,000.00","shares_owned_after":151962.0,"shares_owned_after_display":"151,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-01","filed_date":"2016-11-01","scope":"insider"},{"id":3268402,"accession":"0001450324-16-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001450324-16-000014","line_url":"/filing/0001450324-16-000014#line-1","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K.","owner_url":"/insider/0001450324","role":"Director, Officer (CEO, President)","officer_title":"CEO, President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":48000.0,"shares_display":"48,000","price_per_share":0.1184,"price_display":"0.12","price_state":"stated","total_value":5683.2,"total_display":"5,683.20","shares_owned_after":1703548.0,"shares_owned_after_display":"1,703,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-08","filed_date":"2016-07-08","scope":"insider"},{"id":2049209,"accession":"0001450324-16-000013","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001450324-16-000013","line_url":"/filing/0001450324-16-000013#line-6","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K.","owner_url":"/insider/0001450324","role":"Director, Officer (CEO,President)","officer_title":"CEO,President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28000.0,"shares_display":"28,000","price_per_share":0.1194,"price_display":"0.12","price_state":"stated","total_value":3343.2,"total_display":"3,343.20","shares_owned_after":1627548.0,"shares_owned_after_display":"1,627,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-01","filed_date":"2016-07-01","scope":"insider"},{"id":2049207,"accession":"0001450324-16-000013","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001450324-16-000013","line_url":"/filing/0001450324-16-000013#line-5","is_derivative":false,"issuer_cik":"0000946644","issuer_name":"HEMISPHERX BIOPHARMA INC","issuer_ticker":"HEB","issuer_name_source":null,"issuer_url":"/issuer/0000946644","owner_cik":"0001450324","owner_name":"Equels Thomas K.","owner_url":"/insider/0001450324","role":"Director, Officer (CEO,President)","officer_title":"CEO,President","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":28000.0,"shares_display":"28,000","price_per_share":0.1186,"price_display":"0.12","price_state":"stated","total_value":3320.8,"total_display":"3,320.80","shares_owned_after":1655548.0,"shares_owned_after_display":"1,655,548","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-07-01","filed_date":"2016-07-01","scope":"insider"}],"next_cursor":"2016-07-01|2049207","ledger_fault":false,"count":{"value":67,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":67,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":67},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000946644","name":"AIM ImmunoTech Inc.","url":"/issuer/0000946644","role":"Director, Officer (CEO & President)","n_filings":51,"first_seen":"2015-04-15","last_seen":"2025-06-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001450324","retrieved_at":"2026-08-21T20:38:48+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}